Phenotypic knock-out of the latent membrane protein 1 of Epstein–Barr virus by an intracellular single-chain antibody (original) (raw)

Gene Therapy volume 5, pages 1171–1179 (1998)Cite this article

Abstract

Epstein–Barr virus (EBV) causes lymphoproliferative diseases in immunocompromised patients and is associated with endemic Burkitt lymphoma, nasopharyngeal carcinoma and some cases of Hodgkin disease. The latent membrane protein 1 (LMP1) of EBV is a transmembrane protein that is essential for the transformation of B lymphocytes. LMP1-mediated up-regulation of Bcl-2 is thought to be an important element in this process. As an approach to explore novel treatments for EBV-associated lymphomas, we constructed a single-chain antibody (sFv) directed against LMP1 to achieve functional inhibition of this oncoprotein in EBV-transformed B lymphocytes. We demonstrated that intracellular expression of an endoplasmic reticulum (ER)-targeted form of this sFv markedly reduced LMP1 protein levels. We also observed a decrease in intracellular level of this protein which correlated with a marked reduction of Bcl-2 expression in EBV-transformed B lymphocytes. We further demonstrated that anti-LMP1 sFv-mediated reduction of Bcl-2 correlated with increased sensitivity of these cells to drug-induced cell death. Therefore, these data suggest that an anti-LMP1 sFv used in combination with conventional chemotherapy may be useful for gene therapy of EBV-associated lymphomas in immunocompromised patients.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 6 print issues and online access

$259.00 per year

only $43.17 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Gene Therapy Program, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA
    A Piché, K Kasono, F Johanning & DT Curiel
  2. Divisions of Infectious Diseases and Medical Oncology, University of Colorado Health Sciences Center, Denver, CO, USA
    TJ Curiel

Authors

  1. A Piché
    You can also search for this author inPubMed Google Scholar
  2. K Kasono
    You can also search for this author inPubMed Google Scholar
  3. F Johanning
    You can also search for this author inPubMed Google Scholar
  4. TJ Curiel
    You can also search for this author inPubMed Google Scholar
  5. DT Curiel
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Piché, A., Kasono, K., Johanning, F. et al. Phenotypic knock-out of the latent membrane protein 1 of Epstein–Barr virus by an intracellular single-chain antibody.Gene Ther 5, 1171–1179 (1998). https://doi.org/10.1038/sj.gt.3300706

Download citation

Keywords

This article is cited by